DNA repair status of high-grade serous ovarian cancer change in a treatment course

被引:0
作者
Takaya, Hisamitsu [1 ]
Nakai, Hidekatsu [1 ]
Sakai, Kazuko [2 ]
Nishio, Kazuto [2 ]
Matsumura, Noriomi [1 ]
机构
[1] Kindai Univ, Dept Obst & Gynecol, Higashiosaka, Osaka, Japan
[2] Kindai Univ, Dept Genome Biol, Higashiosaka, Osaka, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P7-2-7
引用
收藏
页码:363 / 363
页数:1
相关论文
共 50 条
  • [41] Prexasertib: an investigational checkpoint kinase inhibitor for the treatment of high-grade serous ovarian cancer
    Evangelisti, Giulio
    Barra, Fabio
    Moioli, Melita
    Sala, Paolo
    Stigliani, Sara
    Gustavino, Claudio
    Costantini, Sergio
    Ferrero, Simone
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (08) : 779 - 792
  • [42] Differential DNA methylation in high-grade serous ovarian cancer (HGSOC) is associated with tumor behavior
    Henry D. Reyes
    Eric J. Devor
    Akshaya Warrier
    Andreea M. Newtson
    Jordan Mattson
    Vincent Wagner
    Gabrielle N. Duncan
    Kimberly K. Leslie
    Jesus Gonzalez-Bosquet
    Scientific Reports, 9
  • [43] Differential DNA methylation in high-grade serous ovarian cancer (HGSOC) is associated with tumor behavior
    Reyes, Henry D.
    Devor, Eric J.
    Warrier, Akshaya
    Newtson, Andreea M.
    Mattson, Jordan
    Wagner, Vincent
    Duncan, Gabrielle N.
    Leslie, Kimberly K.
    Gonzalez-Bosquet, Jesus
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [44] Prevalence of viral DNA in high-grade serous epithelial ovarian cancer and correlation with clinical outcomes
    Robertson, Sharon E.
    Yasukawa, Maya
    Marchion, Douglas C.
    Xiong, Yin
    Naqvi, Syeda Mahrukh Hussnain
    Gheit, Tarik
    Tommasino, Massimo
    Wenham, Robert M.
    Giuliano, Anna R.
    Lancaster, Johnathan M.
    Shahzad, Mian M. K.
    PLOS ONE, 2023, 18 (12):
  • [45] High-grade serous ovarian cancer DNA methylation and survival in African-American women
    Salas, Lucas A.
    Peres, Lauren C.
    Abbott, Sarah E.
    Greene, Casey S.
    Marks, Jeffrey R.
    Alberg, Anthony J.
    Bandera, Elisa V.
    Barnholtz-Sloan, Jill S.
    Schwartz, Ann G.
    Cote, Michele L.
    Moorman, Patricia G.
    Funkhouser, Ellen M.
    Peters, Edward S.
    Bondy, Melissa L.
    Terry, Paul D.
    Doherty, Jennifer A.
    Christensen, Brock C.
    Schildkraut, Joellen M.
    CANCER RESEARCH, 2018, 78 (13)
  • [46] Immunobiology of high-grade serous ovarian cancer: lessons for clinical translation
    Lana E. Kandalaft
    Denarda Dangaj Laniti
    George Coukos
    Nature Reviews Cancer, 2022, 22 : 640 - 656
  • [47] Role of integrins in the metastatic spread of high-grade serous ovarian cancer
    Slavomir Krajnak
    Jörg Jäkel
    Katharina Anić
    Roxana Schwab
    Marcus Schmidt
    Annette Hasenburg
    Wilfried Roth
    Walburgis Brenner
    Marco Johannes Battista
    Archives of Gynecology and Obstetrics, 2022, 305 : 1291 - 1298
  • [48] High-grade serous ovarian cancer (HGSOC) with fallopian tube involvement
    Tanase, Adina Elena
    Solomon-condriuc, Iustina Petra
    Mogos, Raluca Anamaria
    Costachescu, Gabriel
    David, Cristina
    Buzduga, Catalin Mihai
    Scripcariu, Dragos Viorel
    Costea, Claudia Florida
    Cucu, Andrei Ionut
    Tanase, Gabriel Valentin
    Tanase, Daniela Maria
    Nemescu, Dragos
    Dumitrescu, Ana Maria
    Carauleanu, Alexandru
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2024, 65 (02) : 325 - 329
  • [49] Targeting DUSP Activity as a Treatment for High-Grade Serous Ovarian Carcinoma
    Sanders, Brooke E.
    Yamamoto, Tomomi M.
    McMellen, Alexandra
    Woodruff, Elizabeth R.
    Berning, Amber
    Post, Miriam D.
    Bitler, Benjamin G.
    MOLECULAR CANCER THERAPEUTICS, 2022, 21 (08) : 1285 - 1295
  • [50] A single-cell landscape of high-grade serous ovarian cancer
    Benjamin Izar
    Itay Tirosh
    Elizabeth H. Stover
    Isaac Wakiro
    Michael S. Cuoco
    Idan Alter
    Christopher Rodman
    Rachel Leeson
    Mei-Ju Su
    Parin Shah
    Marcin Iwanicki
    Sarah R. Walker
    Abhay Kanodia
    Johannes C. Melms
    Shaolin Mei
    Jia-Ren Lin
    Caroline B. M. Porter
    Michal Slyper
    Julia Waldman
    Livnat Jerby-Arnon
    Orr Ashenberg
    Titus J. Brinker
    Caitlin Mills
    Meri Rogava
    Sébastien Vigneau
    Peter K. Sorger
    Levi A. Garraway
    Panagiotis A. Konstantinopoulos
    Joyce F. Liu
    Ursula Matulonis
    Bruce E. Johnson
    Orit Rozenblatt-Rosen
    Asaf Rotem
    Aviv Regev
    Nature Medicine, 2020, 26 : 1271 - 1279